Biography
Dr. Iwasiow completed a post-doctoral fellowship at the National Research Council of Canada and he holds a Ph.D. degree in Cellular and Molecular Medicine from the University of Ottawa. Dr. Iwasiow he has held various positions across Research and Product Development at DNA Genotek where he and his team contribute significantly to the company's patent portfolio in numerous areas including nucleic acid stabilization methods and physical sample collection devices. Dr. Iwasiow advanced his career within the organization, resulting in the appointment to his current role of Vice President of Innovation and Technology. Under his leadership, the team contributed to successful 510(k) clearances of Oragene•Dx, the first non-invasive DNA collection device for at-home and direct to consumer use. Most recently his team’s efforts lead to a 510(k) clearance of OMNIgene•GUT Dx, the first of its kind device for self-collection and stabilization of fecal samples for microbiome profiling.

Microbial Profiling Showcase:
DNA Genotek Inc
DNA Genotek Inc., Novosanis and Diversigen are subsidiaries of OraSure Technologies, Inc. working to provide high-quality sample collection products and comprehensive services for sample processing, sequencing, and bioinformatic analysis. Our solutions enable microbiome discovery for academic, pharmaceutical, biotechnology, agricultural and environmental applications.

A New Benchmark for Gut Microbiome Collections
DNA Genotek introduces OMNIgene®•GUT Dx, the first FDA-authorized device for the collection of human fecal samples and assessment of the microbiome profile. Validated using WGS, it provides a stable and reproducible representation of the in-vivo fecal bacterial community composition.